Advertisement

Topics

Adrenergic modifiers - Biotech, Pharma and Life Science Channel

20:23 EDT 25th September 2017 | BioPortfolio

PubMed Articles [353 Associated PubMed Articles listed on BioPortfolio]

Molecular biology of amitraz resistance in cattle ticks of the genus Rhipicephalus.

Amitraz is an important product for the control of cattle ticks around the world. In comparison with other products for the control of ticks, it is quite affordable and it has a rapid knock-down effec...

Associations among left ventricular systolic function, tachycardia, and cardiac preload in septic patients.

In sepsis, tachycardia may indicate low preload, adrenergic stimulation, or both. Adrenergic overstimulation is associated with septic cardiomyopathy. We sought to determine whether tachycardia was as...

Carboxymethyl cyclosophoraoses as a flexible pH-responsive solubilizer for pindolol.

In the present study, cyclosophoraoses (CyS) (β-1,2 linked cyclic glucans, with glucopyranose units ranging from 17 to 23) isolated from Rhizobium leguminosarum biovar viciae VF-39 were modified with...

Biopolymer gels containing fructooligosaccharides.

The influence of the addition of fructooligosaccharide (FOS) in an external gelated alginate/gelatin biopolymer matrix, was evaluated in order to produce biopolymeric structures with functional effect...

Hearing loss without overt metabolic acidosis in ATP6V1B1 deficient MRL mice, a new genetic model for non-syndromic deafness with enlarged vestibular aqueducts.

Mutations of the human ATP6V1B1 gene cause distal renal tubular acidosis (dRTA; OMIM #267300) often associated with sensorineural hearing impairment; however, mice with a knockout mutation of Atp6v1b1...

A modifier of Huntington's disease onset at the MLH1 locus.

Huntington's disease (HD) is a dominantly inherited neurodegenerative disease caused by an expanded CAG repeat in HTT. Many clinical characteristics of HD such as age at motor onset are determined lar...

Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions.

Myotonic dystrophy type 1 (DM1) is caused by a highly unstable expansion of CTG repeats in the DMPK gene. Its huge phenotypic variability cannot be explained solely by the repeat number. Recently, var...

Extracellular Vesicle-Associated RNA as a Carrier of Epigenetic Information.

Post-transcriptional regulation of messenger RNA (mRNA) metabolism and subcellular localization is of the utmost importance both during development and in cell differentiation. Besides carrying geneti...

Comprehensive Analysis of Non-Synonymous Natural Variants of G Protein-Coupled Receptors.

G protein-coupled receptors (GPCRs) are the largest superfamily of transmembrane receptors and have vital signaling functions in various organs. Because of their critical roles in physiology and patho...

Natural outdoor environments and mental health: Stress as a possible mechanism.

Better mental health has been associated with exposure to natural outdoor environments (NOE). However, comprehensive studies including several indicators of exposure and outcomes, potential effect mod...

News Articles [61 Associated News Articles listed on BioPortfolio]

Researchers aim to improve gut health of livestock animals

(University of Delaware) Researchers at the University of Delaware are looking at ways to improve gut health of livestock animals. Many of the projects are funded by industry and look at mechanisms fo...

Global AIM Acrylic Impact Modifier Market Research Report 20112023 [Report Updated: 25082017] Prices from USD $1860

SummaryAcrylicBased Impact Modifiers are used as a plastic additive for rigid plastics particularly for PVC formulation for weather, and heat stability as well as for impact resistance and UV durabili...

Adrenergic Uptake Inhibitor Pipeline Insights, 2017 [Report Updated: 01092017] Prices from USD $2000

DelveInsight's, Adrenergic Uptake InhibitorMechanism of action Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Adrenergic Uptake Inhib...

Global Rheology Modifiers Market Research Report Forecast 20172022 [Report Updated: 18062017] Prices from USD $2800

Delivery of the Report will take 4872 hours once order is placed.The Global Rheology Modifiers Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategis...

Trelegy Ellipta Approved as the First Once-Daily Single Inhaler Triple Therapy for the Treatment of Appropriate Patients with COPD in the US

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) has approved once-daily, single inhaler triple...

Visceral Pain Pipeline Review, H2 2017 [Report Updated: 16082017] Prices from USD $2000

Visceral Pain Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Visceral Pain Pipeline Review, H2 2017, provides an overview of the V...

Trelegy Ellipta Once-Daily Single Inhaler Triple Therapy Receives Positive Opinion from the CHMP in Europe for Appropriate Patients with COPD

GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (...

Beta-adrenergic receptor signaling affects tumor microenvironment

(HealthDay)—β2-adrenergic receptor (β-AR) signaling in host immune cells regulates CD8+ T-cell frequency and functional orientation within the tumor microenvironment, according to a study publishe...

Migraine “Modifiers” - a New Concept Emerges from Curelator HeadacheTM Platform

For the first time Curelator Headache, a novel digital health platform, has sorted risk factors for each individual user’s migraine attacks into sets of highly personalized “modifiers” of migrai...

Michelman Showing Fiber Sizing Product Breadth and New Solutions at CAMX 2017

Michelman will showcase a range of new and improved Hydrosize fiber sizing solutions at CAMX 2017 including Hydrosize PA874, Hydrosize U5-01, and Hydrosize HP-1632. These and other solutions can be di...

Events [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Addivant

Addivant™ is an innovator in the field of polymer additives, developing customized solutions that provide customers enhanced application performance, safe handling, and reduc...

Partikula LLC

Partikula is a preclinical stage biotechnology company focused on developing novel therapies for cancer and other diseases based on platform chemistry technologies, including its ...

Innate Immunotherapeutics Limited

Innate Immunotherapeutics Limited is a public unlisted biopharmaceutical company based in Auckland, New Zealand. The company is focused on the development of a new generation of i...

Innate Therapeutics Limited

Innate Therapeutics Limited is a public unlisted biopharmaceutical company based in Auckland. The company is focused on the development of a new generation of immune response modi...

Clinical Trials [153 Associated Clinical Trials listed on BioPortfolio]

Beta Adrenergic Antagonist for the Healing of Chronic DFU

One in four Veterans is affected by diabetes and will develop a diabetic foot ulcer. Diabetic ulcers are very challenging to manage and are the most common cause of leg amputation. Many ad...

Studies in Patients With Tuberous Sclerosis Complex

This study is aimed to carry out a systematic study to examine the effects of genetic variants (genetic modifiers) other than TSC genes on phenotypic variability in familial TSC patients (...

A Double-blind Study on Molecular Genetics of Drug Responsiveness in Essential Hypertension

Blood pressure variation and the risk of essential hypertension have an important genetic component. In most cases susceptibility to essential hypertension is likely determined by the acti...

Effect of Inhaled Albuterol in Pulmonary Hypertension

The purpose of the present pilot study is to test the hypothesis that in patients with group 1 pulmonary arterial hypertension (PAH) who are on regular oral pulmonary vasodilator therapy, ...

Magnesium and Postoperative Pain

With ongoing advancements in healthcare leading to prolonged life expectancy, orthopedic surgeries are increasingly performed in elderly patients. Total knee arthroplasty, in particular, h...

SSEP Fluctuations Due to Dexmedetomidine During Posterior Spine Fusion

Intravenous anesthetic agents as far as inhaled agents produce a dose depended increase in latency and decrease in amplitude of SomatoSensory Evoked Potential (SSEP). Dexmetedomidine, a hi...

Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2

Septic shock is a common syndrome caused by the body's response to an infection. Septic shock is responsible for 10% of all ICU admissions and 30% of ICU deaths. Use of "beta blocker" medi...

Comparison Between Epinephrine and Clonidine as Adjuvants to Lidocaine in Axillary Brachial Plexus Block.

Adjuncts to local anaesthetics for the peripheral nerve blocks such as epinephrine, clonidine and opioids have been widely used to enhance quality, duration of anaesthesia and postoperativ...

Prevelance of Fragmented QRS Complex and Prolonged QT Interval in Cirrhotic Patients

.Cardiac affection in liver cirrhosis is a clinical condition characterized by impaired diastolic relaxation and contractility with electrophysiological abnormalities. .Cirrhotic patients...

Comparative Low and High Dose of Dexmedethomidine in Pituitary Tumor Removal by Transphenoid Approach

Transnasal transsphenoidal (TNTS) resection of pituitary tumors involves wide fluctuation in hemodynamic parameter and causes hypertension and tachycardia due to intense noxious stimuli du...

Videos

None available.

Medical and Biotech [MESH] Definitions

Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters.

Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE.

A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). beta-3 Adrenergic receptors are the predominant beta-adrenergic receptor type expressed in white and brown ADIPOCYTES and are involved in modulating ENERGY METABOLISM and THERMOGENESIS.

Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.

Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.

Quick Search
Advertisement
 
review and buy Adrenergic modifiers market research data and corporate reports here

Channels Quicklinks